QUality Of Life and surviVAl in carDIac arreSt Patients (QUOVADIS)

Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva

Status: Not yet enrolling

Conditions: Post-Anoxic Coma; Central Nervous System Diseases; Cardiac Arrest

Treatments: Other: Intensive care treatment

Study type: Observational

Funder types: Other

Identifiers

NCT04129073

QUO VADIS

Details and patient eligibility

About

QUO VADIS is a national observational study with the aim to describe clinical intervention and utilization of neuroprognostication tools in the management of patients admitted to ICU following cardiac arrest

Full description

Despite recent improvements in post-resuscitation care, about 50% of patients resuscitated from cardiac arrest die or have poor neurological prognosis. Post-anoxic brain injury is common after cardiac arrest and is a major cause of post-resuscitation mortality. Since there has been a significant investment in improving the emergency response to both in-hospital ad out-of-hospital cardiac arrest (IHCA and OHCA, respectevly) patients and reported improvements in short-term survival outcomes, the long-term neurological state and quality of life of survivors and their caregiver is of growing significance.

QUO VADIS is a national observational study created to describe clinical interventions and utilization of neuroprognostication tools in the management of patients admitted to ICU following cardiac arrest.

The aims of the study are:

• To create an Italian Registry that describes clinical interventions and neuroprognostication tools used in the management of patients admitted to ICU following cardiac arrest
• To evaluate, after one year from the cardiac arrest, the neurological outcome and the quality of life of the patients;
• To evaluate, after one year from the cardiac arrest, the quality of life of caregivers;
• To identify the most effective clinical intervention in the management of post-cardiac arrest patients admitted to ICU;
• To create a prognostic model for patients admitted to ICU after cardiac arrest.

Enrollment: 1,600 estimated patients

Sex: All

Ages: 14+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 14 years;
• Cardiac Arrest within 24 hours ICU admission

Exclusion criteria

• Absence of Informed consent;
• Age < 14 years

Trial design

1,600 participants in 1 patient group

Cardiac arrest patients admitted to Intensive Care treatment

Description:

Intensive Care treatment; Utilization of neuroprognostication tools

Treatment:

Other: Intensive care treatment